Anti-PLAC9 functional antibody

Anti-PLAC9 functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to PLAC9/PLAC9 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-SE1193-Ab-1/ GM-Tg-hg-SE1193-Ab-2Anti-Human PLAC9 monoclonal antibodyHuman
GM-Tg-rg-SE1193-Ab-1/ GM-Tg-rg-SE1193-Ab-2Anti-Rat PLAC9 monoclonal antibodyRat
GM-Tg-mg-SE1193-Ab-1/ GM-Tg-mg-SE1193-Ab-2Anti-Mouse PLAC9 monoclonal antibodyMouse
GM-Tg-cynog-SE1193-Ab-1/ GM-Tg-cynog-SE1193-Ab-2Anti-Cynomolgus/ Rhesus macaque PLAC9 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-SE1193-Ab-1/ GM-Tg-felg-SE1193-Ab-2Anti-Feline PLAC9 monoclonal antibodyFeline
GM-Tg-cang-SE1193-Ab-1/ GM-Tg-cang-SE1193-Ab-2Anti-Canine PLAC9 monoclonal antibodyCanine
GM-Tg-bovg-SE1193-Ab-1/ GM-Tg-bovg-SE1193-Ab-2Anti-Bovine PLAC9 monoclonal antibodyBovine
GM-Tg-equg-SE1193-Ab-1/ GM-Tg-equg-SE1193-Ab-2Anti-Equine PLAC9 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-SE1193-Ab-1/ GM-Tg-hg-SE1193-Ab-2; GM-Tg-rg-SE1193-Ab-1/ GM-Tg-rg-SE1193-Ab-2;
GM-Tg-mg-SE1193-Ab-1/ GM-Tg-mg-SE1193-Ab-2; GM-Tg-cynog-SE1193-Ab-1/ GM-Tg-cynog-SE1193-Ab-2;
GM-Tg-felg-SE1193-Ab-1/ GM-Tg-felg-SE1193-Ab-2; GM-Tg-cang-SE1193-Ab-1/ GM-Tg-cang-SE1193-Ab-2;
GM-Tg-bovg-SE1193-Ab-1/ GM-Tg-bovg-SE1193-Ab-2; GM-Tg-equg-SE1193-Ab-1/ GM-Tg-equg-SE1193-Ab-2
Products NameAnti-PLAC9 monoclonal antibody
Formatmab
Target NamePLAC9
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-PLAC9 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-SE1193-Ag-1Recombinant multi-species PLAC9 protein
    ORF Viral VectorvGMLP000613human PLAC9 Lentivirus particle
    ORF Viral VectorpGMLP000613human PLAC9 Lentivirus plasmid


    Target information

    Target IDGM-SE1193
    Target NamePLAC9
    Gene ID219348,211623,361105,114669722,119871489,101100336,510496,100073023
    Gene Symbol and SynonymsGm10393,Gm9780,PLAC9,Plac9a,Plac9b
    Uniprot AccessionQ5JTB6,Q2TBK3
    Uniprot Entry NamePLAC9_HUMAN,PLAC9_BOVIN
    Protein Sub-locationSecreted Protein/Potential Cytokines
    Category
    DiseaseN/A
    Gene EnsemblENSG00000189129
    Target ClassificationN/A

    The target: PLAC9, gene name: PLAC9, also named as . Predicted to be located in extracellular region. [provided by Alliance of Genome Resources, Apr 2022].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.